购物车
- 全部删除
- 您的购物车当前为空
CYP4A11/CYP4F2-IN-2(compound 15)作为一种口服抑制剂,其针对CYP4A11及CYP4F2 的IC50s 分别为 120 nM 和 220 nM。该化合物能够有效抑制大鼠肾中的20-HETE生成,显示出对尿病肾病和常染色体显性多囊肾病治疗的潜力。
CYP4A11/CYP4F2-IN-2(compound 15)作为一种口服抑制剂,其针对CYP4A11及CYP4F2 的IC50s 分别为 120 nM 和 220 nM。该化合物能够有效抑制大鼠肾中的20-HETE生成,显示出对尿病肾病和常染色体显性多囊肾病治疗的潜力。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
10 mg | 询价 | 10-14周 | |
50 mg | 询价 | 10-14周 |
产品描述 | CYP4A11/CYP4F2-IN-2 (compound 15) serves as an orally administered inhibitor targeting CYP4A11/4F2, exhibiting IC50 values of 120 nM and 220 nM, respectively. This compound effectively suppresses 20-HETE production within the rat kidney and shows promise in mitigating the progression of diabetic nephropathy and autosomal dominant polycystic kidney disease [1]. |
分子量 | 361.44 |
分子式 | C19H27N3O4 |
CAS No. | 2280834-99-1 |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.